Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5′TOP mRNA translation

Genes and Development

Volumn 28, Issue 4, 2014, Pages 357-371

  Tcherkezian, Joseph ^a   Cargnello, Marie ^a   Romeo, Yves ^b,c   Huttlin, Edward L ^d   Lavoie, Genevieve ^a   Gygi, Steven P ^d   Roux, Philippe P ^a,e  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b CNRS   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

5 TOP; LARP1; mRNA; mTOR; Proteomics; Translation

Indexed keywords

5′TOP; LARP1; MRNA; MTOR; PROTEOMICS; TRANSLATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; AUTOANTIGENS; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; MICE; PROTEOMICS; PYRIMIDINES; RIBONUCLEOPROTEINS; RNA CAP-BINDING PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84893912480     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.231407.113     Document Type: Article

References (45)

1. Alain T, Morita M, Fonseca BD, Yanagiya A, Siddiqui N, Bhat M, Zammit D, Marcus V, Metrakos P, Voyer LA, et al. 2012. eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies. Cancer Res 72: 6468-6476.
2. Aoki K, Adachi S, Homoto M, Kusano H, Koike K, Natsume T. 2013. LARP1 specifically recognizes the 39 terminus of poly(A) mRNA. FEBS Lett 587: 2173-2178.
3. Avni D, Biberman Y, Meyuhas O. 1997. The 59 terminal oligopyrimidine tract confers translational control on TOP mRNAs in a cell type-and sequence context-dependent manner. Nucleic Acids Res 25: 995-1001.
4. Bayfield MA, Yang R, Maraia RJ. 2010. Conserved and divergent features of the structure and function of La and La-related proteins (LARPs). Biochim Biophys Acta 1799: 365-378.
5. Blagden SP, Gatt MK, Archambault V, Lada K, Ichihara K, Lilley KS, Inoue YH, Glover DM. 2009. Drosophila Larp associates with poly(A)-binding protein and is required for male fertility and syncytial embryo development. Dev Biol 334: 186-197.
6. Burrows C, Abd Latip N, Lam SJ, Carpenter L, Sawicka K, Tzolovsky G, Gabra H, Bushell M, Glover DM, Willis AE, et al. 2010. The RNA binding protein Larp1 regulates cell division, apoptosis and cell migration. Nucleic Acids Res 38: 5542-5553.
7. Cardinali B, Carissimi C, Gravina P, Pierandrei-Amaldi P. 2003. La protein is associated with terminal oligopyrimidine mRNAs in actively translating polysomes. J Biol Chem 278: 35145-35151.
8. Chauvet S, Maurel-Zaffran C, Miassod R, Jullien N, Pradel J, Aragnol D. 2000. dlarp, a new candidate Hox target in Drosophila whose orthologue in mouse is expressed at sites of epithelium/mesenchymal interactions. Dev Dyn 218: 401-413.
9. Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, et al. 2002. Gene expression patterns in human liver cancers. Mol Biol Cell 13: 1929-1939.
10. Crosio C, Boyl PP, Loreni F, Pierandrei-Amaldi P, Amaldi F. 2000. La protein has a positive effect on the translation of TOP mRNAs in vivo. Nucleic Acids Res 28: 2927-2934.
11. Damgaard CK, Lykke-Andersen J. 2011. Translational coregulation of 59TOP mRNAs by TIA-1 and TIAR. Genes Dev 25: 2057-2068.
12. Dowling RJ, Topisirovic I, Alain T, Bidinosti M, Fonseca BD, Petroulakis E, Wang X, Larsson O, Selvaraj A, Liu Y, et al. 2010. mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 328: 1172-1176.
13. Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J. 2004. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol 24: 200-216.
14. Foster KG, Fingar DC. 2010. Mammalian target of rapamycin (mTOR): Conducting the cellular signaling symphony. J Biol Chem 285: 14071-14077.
15. Gentilella A, Thomas G. 2012. Cancer biology: The director's cut. Nature 485: 50-51.
16. Hogan DJ, Riordan DP, Gerber AP, Herschlag D, Brown PO. 2008. Diverse RNA-binding proteins interact with functionally related sets of RNAs, suggesting an extensive regulatory system. PLo S Biol 6: e255.
17. Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, Shi EY, Stumpf CR, Christensen C, Bonham MJ, et al. 2012. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485: 55-61.
18. Hsu PP, Kang SA, Rameseder J, Zhang Y, Ottina KA, Lim D, Peterson TR, Choi Y, Gray NS, Yaffe MB, et al. 2011. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332: 1317-1322.
19. Ivanov P, Kedersha N, Anderson P. 2011. Stress puts TIA on TOP. Genes Dev 25: 2119-2124.
20. Jacinto E. 2008. What controls TOR? IUBMB Life 60: 483-496.
21. Jefferies HB, Reinhard C, Kozma SC, Thomas G. 1994. Rapamycin selectively represses translation of the 'polypyrimidine tract' mRNA family. Proc Natl Acad Sci 91: 4441-4445.
22. Kakegawa T, Ohuchi N, Hayakawa A, Hirata S, Matsuda M, Kogure K, Kobayashi H, Inoue A, Kaspar RL. 2007. Identification of AUF1 as a rapamycin-responsive binding protein to the 59-terminal oligopyrimidine element of mRNAs. Arch Biochem Biophys 465: 274-281.
23. Koromilas AE, Lazaris-Karatzas A, Sonenberg N. 1992. mRNAs containing extensive secondary structure in their 59 noncoding region translate efficiently in cells overexpressing initiation factor eIF-4E. EMBO J 11: 4153-4158.
24. Laplante M, Sabatini DM. 2012. mTOR signaling in growth control and disease. Cell 149: 274-293.
25. Ma XM, Blenis J. 2009. Molecular mechanisms of mTORmediated translational control. Nat Rev Mol Cell Biol 10: 307-318.
26. Markert A, Grimm M, Martinez J, Wiesner J, Meyerhans A, Meyuhas O, Sickmann A, Fischer U. 2008. The La-related protein LARP7 is a component of the 7SK ribonucleoprotein and affects transcription of cellular and viral polymerase II genes. EMBO Rep 9: 569-575.
27. Meyuhas O. 2000. Synthesis of the translational apparatus is regulated at the translational level. Eur J Biochem 267: 6321-6330.
28. Nykamp K, Lee MH, Kimble J. 2008. C. elegans La-related protein, LARP-1, localizes to germline P bodies and attenuates Ras-MAPK signaling during oogenesis. RNA 14: 1378-1389.
29. Pause A, Belsham GJ, Gingras A, Donze O, Lin T, Lawrence JCJ, Sonenberg N. 1994. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 59-cap function. Nature 371: 762-767.
30. Pellizzoni L, Cardinali B, Lin-Marq N, Mercanti D, Pierandrei-Amaldi P. 1996. A Xenopus laevis homologue of the La autoantigen binds the pyrimidine tract of the 59 UTR of ribosomal protein mRNAs in vitro: Implication of a protein factor in complex formation. J Mol Biol 259: 904-915.
31. Pestova TV, Shatsky IN, Hellen CU. 1996. Functional dissection of eukaryotic initiation factor 4F: The 4A subunit and the central domain of the 4G subunit are sufficient to mediate internal entry of 43S preinitiation complexes. Mol Cell Biol 16: 6870-6878.
32. Polak P, Hall MN. 2009. mTOR and the control of whole body metabolism. Curr Opin Cell Biol 21: 209-218.
33. Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX, et al. 2010. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res 70: 10202-10212.
34. Roux PP, Topisirovic I. 2012. Regulation of mRNA translation by signaling pathways. Cold Spring Harb Perspect Biol 4: a012252.
35. Sengupta S, Peterson TR, Sabatini DM. 2010. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 40: 310-322.
36. Shama S, Avni D, Frederickson RM, Sonenberg N, Meyuhas O. 1995. Overexpression of initiation factor eIF-4E does not relieve the translational repression of ribosomal protein mRNAs in quiescent cells. Gene Expr 4: 241-252.
37. Sonenberg N. 2008. eIF4E, the mRNA cap-binding protein: From basic discovery to translational research. Biochem Cell Biol 86: 178-183.
38. Sonenberg N, Morgan MA, Merrick WC, Shatkin AJ. 1978. A polypeptide in eukaryotic initiation factors that crosslinks specifically to the 59-terminal cap in mRNA. Proc Natl Acad Sci 75: 4843-4847.
39. Soto-Rifo R, Rubilar PS, Limousin T, de Breyne S, Decimo D, Ohlmann T. 2012. DEAD-box protein DDX3 associates with eIF4F to promote translation of selected mRNAs. EMBO J 31: 3745-3756.
40. Tcherkezian J, Brittis PA, Thomas F, Roux PP, Flanagan JG. 2010. Transmembrane receptor DCC associates with protein synthesis machinery and regulates translation. Cell 141: 632-644.
41. Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM. 2012. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485: 109-113.
42. Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J, et al. 2007. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 45: 938-947.
43. Xie C, Huang L, Xie S, Xie D, Zhang G, Wang P, Peng L, Gao Z. 2013. LARP1 predict the prognosis for early-stage and AFPnormal hepatocellular carcinoma. J Transl Med 11: 272.
44. Yu Y, Yoon SO, Poulogiannis G, Yang Q, Ma XM, Villen J, Kubica N, Hoffman GR, Cantley LC, Gygi SP, et al. 2011. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332: 1322-1326.
45. Zhang Y, Ling J, Yuan C, Dubruille R, Emery P. 2013. A role for Drosophila ATX2 in activation of PER translation and circadian behavior. Science 340: 879-882.